Analysts/Institutional Investor Meet/Con. Call Updates

July 24, 2026 Ref:- GHL/2026-27/EXCH/32 The General Manager The Manager Dept. of Corporate Services Listing Department BSE Limited, National Stock Exchange of India Limited P J Towers, Dalal Street, Exchange Plaza, C-1, Block G, Mumbai - 400 001 Bandra Kurla Complex, Bandra (E), Mumbai - 400 051 Scrip Code: 543654 Symbol: MEDANTA Sub: Intimation for Earnings Conference Call under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 Dear Sir(s), Pursuant to Regulation 30 read with Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform you that Earnings Conference Call has been scheduled for Friday, July 31, 2026 at 02:00 P.M. (IST). The call will be hosted by JM Financial for the first Quarter ended June 30, 2026 financial results. The details of earning call is enclosed herewith and is also available on the website of the Company at https://www.medanta.org/ Kindly take the above on record. For Global Health Limited Rahul Ranjan Company Secretary & Compliance Officer M. No. A17035 Encl: a/a Regd. Office: E-18, Defence Colony, New Delhi 110024, Ph No.011- 44114411 www.medanta.org, info@medanta.org, CIN: L85110DL2004PLC128319 Global Health Limited Q1 FY2027 Earnings Conference Call Friday, 31st July, 2026 at 2:00 PM IST 4:30 AM USA EST | 9:30 AM UK Time | 4:30 PM HK/Singapore Time Global Health Limited (Medanta): The management of the company is pleased to invite you to the Q1 FY2027 results conference call hosted by JM Financial on Friday, 31st July, 2026 at 2:00 PM. The management team will be represented by: Dr. Naresh Trehan – Chairman & Managing Director Mr. Pankaj Sahni – Group CEO & Director Mr. Yogesh Kumar Gupta – Chief Financial Officer Mr. Gaurav Chugh – Head Investor Relations Details of the conference call are as under: Date and Time: 31st July, 2026 (Friday) at 2:00 PM IST Universal Dial In: +91-22-7195 0000 Toll Free Numbers - International Singapore: 800 101 1997 Hong Kong: 800 900 919 USA: 1 877 271 3944 UK: 0 808 101 1132 Please register in advance using the link given below; most convenient method to connect with zero wait time: For further information, please contact: JM Financial Institutional Securities Amey Chalke: +91 96649 76620 amey.chalke@jmfl.com Global Health Limited Gaurav Chugh - Head Investor Relations Bhushan Khandelwal - Investor Relations Investor.relations@medanta.org About Medanta: Founded by Dr. Naresh Trehan, a world-renowned cardiovascular and cardiothoracic surgeon who has been awarded the prestigious Padma Bhushan and the Padma Shri, the third- and fourth-highest civilian awards in India, and the Dr. B.C. Roy Award in recognition of his distinguished contribution to medicine. Global Health Limited (the “Company”) is one of the largest private multi-specialty tertiary care providers operating in the North and East regions of India, with key specialties cardiac science, neurosciences, oncology, digestive and hepatobiliary sciences, orthopedics, liver transplant, and kidney and urology, according to the report titled “An assessment of the healthcare delivery market in India, September 2022” by CRISIL Limited. Under the “Medanta” brand, the Company has a network of six hospitals currently in operation (Gurgaon, Indore, Ranchi, Lucknow, Patna and Noida). Spanning an area of 5.6 million sq.ft., its operational hospitals have 3,665 installed beds as on March 31, 2026. It also has five upcoming hospitals in Mumbai, Guwahati, Varanasi and two hospitals in Delhi. The Company provides healthcare services in over 30 medical specialties and engages over 2,400+ doctors led by highly experienced department heads. For more information please log onto: www.medanta.org